Intrinsic Value of S&P & Nasdaq Contact Us

GH Research PLC GHRS NASDAQ

NASDAQ Global Market • Healthcare • Biotechnology • IE • USD

SharesGrow Score
49/100
2/6 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$36.50
+114.7%

There have been 7 recent insider transactions recorded for GH Research PLC (GHRS), including 0 buys and 0 sells.

Notable insiders with recent activity include Schonharting Florian, Forer Michael, Ryan Julie. Insider transactions can provide insights into how company leadership views the stock's valuation and future prospects.

Insider Transactions — GHRS

Date Name Role Transaction Shares Avg. Price Value Shares Owned
2026-04-01 Schonharting Florian Director Unknown - - - 14,824,419
2026-03-18 Forer Michael Director Unknown 4,667 $0.03 $116.68 -
2026-03-18 Ryan Julie VP, Finance Unknown 30,000 $0.03 $750.00 -
2026-03-18 Cameron Aaron Luke Chief Operating Officer Unknown 25,000 $5.80 $145K -
2026-03-18 Halle Magnus Clemensen Managing Director, Ireland Unknown 50,000 $0.03 $1.25K -
2026-03-18 Valcheva Velichka Chief Executive Officer Unknown 300,000 $0.03 $7.5K -
2026-03-18 Hanley Dermot John Director Unknown 4,667 $0.03 $116.68 -
Informative Buy/Sell — open market transaction (most significant) Uninformative Buy — award, option exercise, conversion Uninformative Sell — tax withholding, award vest sale Neutral — gift, trust, expiry
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message